The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2024 | Immunoglobulin gene arrangements as clonal markers in CLL
Anastasia Chatzidimitriou, PhD, Center for Research and Technology Hellas, Thermi, Greece, discusses the role of immunoglobulin gene arrangements as clonal markers in chronic lymphocytic leukemia (CLL). She explains that these markers serve as a molecular fingerprint for tumors, aiding in the differential diagnosis and prognosis of patients. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Unrestricted grants from Novartis, Janssen.
